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Background: The Western Ontario Shoulder Instability index (WOSI) is a patient-reported outcome measure for
patients with shoulder instability. The purpose of this study was to validate the WOSI in a Dutch population by
evaluating its structural validity, internal consistency, measurement error, reliability, and construct validity. Floor and
ceiling effects were also addressed.
Methods: Two cohorts were recruited, including a total of 138 patients with shoulder instability. Confirmatory
factor analysis was used to assess the structural validity and Cronbach’s α to assess internal consistency. The
measurement error was calculated as the smallest detectable change (SDC). Reliability (test–retest) was estimated in
a subgroup of 99 patients who completed the re-test after a mean of 13 days (5–30 days). Reliability was calculated
with the intraclass correlation coefficient (ICC). Construct validity was evaluated by comparing the WOSI with the
Oxford Shoulder Instability Score (OSIS), the Simple Shoulder Test, the Oxford Shoulder Score, the Disability of the
Arm, Shoulder, and Hand assessment (DASH), and the Short Form-36 Health Survey. Measurement properties were
evaluated for both the total WOSI score and its four domains.
Results: Factor analysis did not confirm the validity of the four domains. Best results were found for a one-factor
model. Internal consistency was good, with Cronbach’s α ranging from 0.93 to 0.96. Reliability was excellent
(ICC 0.88–0.92 for all subscales). The measurement error (SDC) was 23.0% for the total WOSI and 23% to 28% for
the subscales (on a scale of 0–100). Regarding the construct validity, 76% of the results were in accordance with
the hypotheses, including a high correlation with the OSIS (0.82) and DASH (0.81) assessments. No floor or ceiling
effects were found.
Conclusion: The Dutch version of WOSI showed good reliability and validity in a cohort of patients with shoulder
instability, although the factor structure remains unclear.
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With an incidence up to 49/100,000 each year, shoulder
instability is commonly seen in orthopaedic clinics [1,2],
generally affecting young and active patients [3,4].
Treatment of shoulder instability aims to provide patients
with a stable shoulder, enable them to perform overhead
activities, and allow them to return to previous (sports)* Correspondence: javdlinde@gmail.com
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article, unless otherwise stated.activities. Results of the treatment of shoulder instability are
evaluated with both objective and subjective outcome
measures. Objective measures include redislocations
and range of motion. Subjective measures include
questionnaires with regard to shoulder function and are
commonly referred to as patient-reported outcomes
measures (PROMs).
PROMs are designed to reflect the patient’s subjective
function, addressing subdomains such as sports, work,
and emotional well-being. They enable the practitioner
to detect functional changes in a standardised way.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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a patient’s health status [5] and can focus on general
health, a physical domain or body part (e.g., the shoulder),
or a certain condition or disease (e.g., instability) [6].
Several PROMs have been developed over time to
evaluate shoulder instability. The Western Ontario
Shoulder Instability Index (WOSI) is a well-designed,
thoroughly evaluated questionnaire that has proved to
be reliable, valid, and sensitive to changes that are of
clinical importance to Canadian patients with shoulder
instability [7], leading to international acceptance. The
WOSI has also been proven useful as an outcome
measure in several clinical studies [8-10] and has been
translated and validated in Italian, German, Swedish, and
Japanese [11-15]. Translation and validation of PROMs
allows comparison of national and international study
results [7,16-19].
The aim of this study was to translate and validate the
WOSI for a Dutch population of patients with shoulder
instability. We evaluated its measurement properties
according to the Consensus-based Standards for the




The WOSI was independently translated into Dutch by an
official translator (Metamorfose Translations, Utrecht, The
Netherlands) and three medically educated translators
whose native language was Dutch [16,19-21]. When they
reached consensus, this version (version 1, or V1) was
completed with the help of 20 patients with shoulder
instability, who noted whether the questions were applic-
able to their daily activities. Another 13 patients, who were
previously treated for shoulder instability, were asked to
complete the Dutch version of the WOSI at home to assess
the comprehensibility of the questions. A few linguistic
adjustments were made accordingly (V2). These 33 patients
were excluded from our final analysis.
This WOSI version was translated back into English
by another official translator (Vertaalbureau Oattes,
Amsterdam, The Netherlands) and by a native English
speaker without a medical background. Both were blinded
to the original version and focused on the linguistic
aspects. Their versions were compared with the original
text. Subsequently, the researchers composed a final
version (V3), taking into account all discrepancies.
Patients and procedures for assessing measurement
properties
Two cohorts of patients with shoulder instability were
recruited to assess reliability and validity. We planned to
include at least 100 patients, which is considered excellent
for assessing measurement properties [16,22].The first cohort included 75 patients with shoulder
instability who visited our outpatient clinic between
December 2009 and December 2011. The second cohort
included 79 patients with shoulder instability who visited
the emergency department or the outpatient clinic between
December 2012 and May 2013. All patients were recruited
at the Onze Lieve Vrouwe Gasthuis, Amsterdam, The
Netherlands.
Inclusion criteria were age 16 years or older and any
form of glenohumeral instability (anterior, posterior,
multidirectional) as diagnosed by one of our doctors.
Exclusion criteria were an inability to master the Dutch
language and a large glenoid fracture or proximal
humeral fracture, such as a displaced fracture of the
greater tuberosity. Hill-Sachs and bony Bankart lesions
were included. Patients who underwent treatment or
follow-up at another clinic were excluded to avoid the
inconvenience of a double follow-up.
All patients were assigned a study number and received
a web-based questionnaire to be completed at home. All
answers were required prior to submission. Patients
lacking Internet access received an identical paper
version. Missing items were completed by telephone.
Patients were asked to complete the questionnaire twice
at an interval of 5 to 30 days, which was considered long
enough to forget prior answers and short enough to
assume an unchanged shoulder condition. Both versions
were either web-based or on paper.
The local ethics committee (METC from the Onze
Lieve Vrouwe Gasthuis) approved the study and written
informed consent was obtained from all patients.
Patient-reported outcomes measurements
Western Ontario Shoulder Instability index
The WOSI is a disease-specific PROM developed by
Kirkley et al. in [23] according to the methodology
described by Kirschner and Guyatt. It was designed to
be used as a primary outcome measure in clinical trials
that evaluated treatments for patients with shoulder
instability [7]. The 21-item questionnaire consists of
four domains, referring to physical symptoms, sport/
recreation/work function, lifestyle function, and emotional
function. Originally responses are given on a 100-mm
visual analogue scale, ranging from no complaints (0 mm)
to severe complaints (100 mm). We created a web-based
version in which patients can choose a score from 0
to 10. Items were summarised in four domain subscores
as a total score, ranging from 0 to 2100, where 0 indicated
no limitations in shoulder-related quality of life and 2100
indicated extreme limitations. The score could also be
expressed as a percentage of normal shoulder function,
where a score of 2100 reflected 0% of normal function
and a score of 0 reflected 100% [24]. The WOSI was
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Shoulder, and Hand (DASH) assessment and the
University of California–Los Angeles (UCLA) shoulder
rating scale, with correlations of 0.77 and 0.65, respectively.
Validation instruments
The following instruments were used to assess the
construct of the validity of the WOSI.
Oxford Shoulder Instability Score
The Oxford Shoulder Instability Score (OSIS) is a disease-
specific PROM developed by Dawson et al. in [21] to
assess treatment for shoulder instability. It was originally
validated against the Rowe and Constant scores, with
correlations of 0.51 and 0.56, respectively. The internal
consistency (Cronbach’s α) was 0.92. The reliability was
0.97, calculated with Pearson’s correlation coefficient [21].
The OSIS is currently being translated and validated in
Dutch in our institution. Unpublished results show good
internal consistency, reliability, and construct validity.
Simple Shoulder Test
The Simple Shoulder Test (SST) is a body-part-specific
PROM that was developed by Matsen and Lippitt et al.
in [25]. It was intended to measure functional limitations
of the affected shoulder in patients with common shoulder
problems, including rotator cuff tears, degenerative
osteoarthritis, and instability [25]. It was validated against
the American Shoulder and Elbow Surgeons (ASES)
survey with a correlation of 0.81. It has recently been
validated in Dutch language, showing high reliability
(interclass correlation coefficient (ICC) 0.92) and high
internal consistency (Cronbach’s α 0.78) [26,27].
Oxford Shoulder Score
The Oxford Shoulder Score (OSS) is a body-part-specific
PROM developed in 1996 by Dawson et al. [28,29]. It was
developed for patients with general shoulder complaints.
The OSS was originally validated against the Constant
Shoulder Score and Short Form-36 Health Survey (SF-36)
subscales, with correlations of −0.74 and −0.66, re-
spectively (the highest correlation was with the SF-36
Pain subscale). It was later validated in Danish [30],
Korean [31], Turkish [32], Italian [33], German [34], and
Dutch. It had high reliability (ICC 0.98) and high internal
consistency (Cronbach’s α 0.92) [35].
Disability of the Arm, Shoulder, and Hand assessment
The Disability of the Arm, Shoulder, and Hand (DASH)
assessment is a body-part-specific PROM. It was developed
in 1996 by the American Association of Orthopaedic
Surgeons to measure physical functions and symptoms in
patients with musculoskeletal disorders caused by any
condition in any joint in the upper extremity. TheDASH was shown to be reliable, valid, and responsive
for patients with shoulder disabilities [36]. It was validated
by Beaton et al. in [37,38]. The DASH was validated in
English against the Shoulder Pain and Disability Index,
and correlations with the pain and function subscales were
0.82 and 0.88, respectively. It was also validated in Dutch
for patients with disorders of the upper limb. It had high
internal consistency (Cronbach’s α 0.95) and reliability
(Pearson’s correlation coefficient 0.98) [39].
Short Form 36 Health Survey, version 1
The Short Form 36 Health Survey (SF-36) is the most
widely used PROM for assessing general health [40]. It
has eight domains: Physical function, Social function, role
limitations caused by physical problems (Role physical),
role limitations caused by emotional problems (Role
emotional), General mental health, Vitality, Bodily pain,
and Perception of general health [41]. The SF-36 was
translated and validated in a Dutch general population
[14]. Previous studies have also validated the SF-36
specifically for shoulder complaints [42,43].
Assessment of measurement properties
Structural validity and internal consistency
Items of PROMs that are being summarised into one
score (either a subscale or total score) should measure the
same construct. Structural validity is defined as the degree
to which the scores of an instrument are an adequate
reflection of the dimensionality (i.e., expected number of
subscales) of the construct to be measured [17]. Thus, in
case of the WOSI, do questions within the subscales
measure the same construct (e.g., physical symptoms,
sport/recreation/work function, lifestyle function, emo-
tional function)? Likewise, do questions from different
subscales measure different constructs?
Structural validity was assessed by confirmatory fac-
tor analyses (CFA) using baseline measurements. We
expected four factors—one for each of the WOSI domains.
Factor loadings represent the correlation between the
items in the questionnaire and the factors (the underlying
dimensions). We examined factor loadings and model fit
with CFA for categorical items, performed in Mplus
(modelling program) using the method of weighted least
squares with mean and variance adjustment.
Factor loadings are generally considered to be
meaningful when they exceed 0.30 or 0.40 [44]. We
considered factor loadings of at least 0.50 appropriate.
The Comparative Fit Index (CFI), Tucker-Lewis Index
(TLI), and the Root Mean Square Error of Approximation
(RMSEA) were used as measures for model fit. A CFI and
TLI of >0.95 and a RMSEA of <0.05 were considered as
adequate fit. For moderate fit, values >0.90 and <0.08 were
used [45]. Because the model did not fit well (see Results),
Table 1 Predetermined hypotheses for testing the
validity of the Dutch version of WOSI: expected and
observed correlations
Expected correlations Observed correlations
1. WOSI and OSIS ≥ 0.7 0.82
2. WOSI and SST ≥ −0.6 - 0.66
3. WOSI and OSS ≥ 0.6 0.79
4. WOSI and DASH ≥ 0.6 0.81
5. Correlation between WOSI and OSIS, both measuring a
disease-specific construct should be at least 0.1 higher
compared with all other correlations.
6. Correlation between similar WOSI and SF-36 domains
should be higher compared with dissimilar domains.
7. Correlation between similar WOSI and SF-36 domains
should be≥ 0.4.
Correlations were calculated using the total WOSI score.
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with SPSS software (SPSS Inc., Chicago, IL, USA), using
the Varimax rotation.
Internal consistency is defined by COSMIN as the
degree of interrelatedness among the items [17].
Items may ask similar questions in slightly different
ways for reliably capturing the respondent’s opinion
or level of function [29]. The internal consistency of
the WOSI was assessed by calculating Cronbach’s α for
each subscale. Cronbach’s α is preferably ≥0.70 [46].
Measurement error and reliability
The measurement error is the systematic and random
error of a patient’s score that is not attributed to true
changes in the patient’s condition [17]. When a patient’s
score changes within the range of the measurement
error, it is unclear whether the change is an effect of the
therapy or should be attributed to a measurement error.
Measurement error can be expressed as the standard
deviation of repeated measurements in a single patient,
which is referred to as the standard error of measurement
(SEM). The SEM was calculated from the square root of
the variance between the measurements and the
error variance of the ICC. Subsequently, the SEM
can be transformed into the smallest detectable
change (SDC = 1.96*√2*SEM), which can be used to
interpret change scores in individual patients over
time. It represents the minimum change a patient
must show to ensure that the observed change is real
and not a measurement error [47].
Reliability is defined as the proportion of the total
variance in the measurements that is due to true dif-
ferences between patients [17]. Reliability is calculated
using the ICC with a two-way mixed-effects model
for absolute agreement. The ICC ranges from 0 (poor
reliability) to 1 (patients with unchanged health status
whose answers would be the same on two occasions).
Scores ≥0.70 are considered adequate [46].
Construct validity
Construct validity refers to the degree to which scores
are consistent with hypotheses regarding relations with
other instruments measuring similar constructs. In this
study, the condition-specific WOSI was compared with
the OSIS, measuring a similar disease-specific construct
(shoulder instability); the SST, OSS, and DASH, assessing
a similar body-specific domain (shoulder); and several
subscales of the original version of SF-36, measuring
general health status. The hypotheses were based on
clinical experience, knowledge of several PROMs, and
consensus among the study investigators. Our hypotheses
are presented in Table 1.
Expected correlation between the WOSI and the OSIS
was ≥0.70. Between the WOSI and the SST, OSS, andDASH assessment it was ≥0.60. The highest correlation
was expected between two PROMs assessing the same
disease-specific construct (WOSI and OSIS, both measur-
ing limitations caused by shoulder instability).
Each WOSI domain was expected to have the highest
correlation with its comparable SF-36 domain: WOSI
Physical symptoms and SF-36 Bodily pain; WOSI Sport/
recreation/work and SF-36 Role functioning; WOSI
Lifestyle and SF-36 Social functioning; WOSI Emotional
function and SF-36 Mental health. These four correlations
were also expected to be at least 0.40.
In total, 79 correlations (or comparisons between
correlations) were evaluated. Construct validity was
considered good when at least 75% of the results were in
accordance with our hypotheses [48].Floor and ceiling effects
Floor and ceiling effects occur when more than 15% of
patients achieve the lowest or highest possible score,
respectively [49]. When patients already have the highest
or lowest possible score before intervention, it is impos-
sible to measure further improvement or deterioration.
When we take the SDC into account we should
consider floor and ceiling effects more broadly. If a score
is close to one of the extremes, and the distance between
the initial score and the extreme is smaller than the
SDC, a change beyond the measurement error cannot
be measured. For this reason, we also assessed how
many scores were observed within the SDC range
from both extremes.Statistical analyses
Statistical analyses were performed using SPSS software
version 18.0.0 and MPlus.
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Translation process
Forward translation of the WOSI into Dutch (V1) did not
impose any problems. No difficulties occurred with the
patients completing the questionnaire under supervision
or at home. Their answers were not used in the subsequent
validation process. Translating the WOSI backward also
did not impose any problems.
Patients
A total of 154 patients with shoulder instability were
recruited, among whom 138 patients (90%) completed
the WOSI. Because retesting was initiated after the first 21
patients had been included, 117 were asked to complete
the WOSI twice. Fifteen patients were either not able or
not willing to participate in the retest. Of the remaining
102 patients, three were excluded because they exceeded
the 30-day interval. In total, 99 (64%) completed a retest. A
flowchart is presented in Figure 1. The mean time between
completion of the first and second questionnaires was
13 days (5–30 days). Sixteen patients completed their first
questionnaire on paper followed by a web-based retest;
four patients completed both questionnaires on paper.
Table 2 shows the patients’ demographic data and the
mean scores of all PROMs at baseline and at retesting.
The mean age at baseline was 32 years. Men were
affected more frequently than women. Both sides of the








Asked to complete re-test
N= 117
Cohort 2                  Cohort 1
Agreed to participate
N= 79
Figure 1 Flowchart showing selection of patients who participated inanterior dislocations. As measured with the OSIS, OSS,
SST, and DASH evaluations, there was no significant
change in shoulder function at baseline and retesting.Structural validity and internal consistency
The expected four-factor model did not fit well: CFI 0.869,
TLI 0.850, RMSEA 0.104. Subsequently, three-factor, two-
factor, and one-factor models were tested by exploratory
factor analyses (Table 3). The best interpretable results
were found with only one factor, although confirmative
testing of this one-factor model in CFA showed worse fit
(CFI 0.800, TLI 0.778, RMSEA 0.127) than the original
four-factor model.
Internal consistency was analysed using baseline
measurements for all 138 patients. For the WOSI domains,
Cronbach’s α was 0.93 for emotional function, 0.94 for
physical symptoms and lifestyle function, and 0.95 for
sports/ recreation/work. For the WOSI total, Cronbach’s α
was 0.96.Measurement error
For the total WOSI score, the SEM was 8.3%, resulting
in an SDC of 23.0%. This indicates that a patient has to
change 23.0 points on a scale from 0 to 100 to detect an
actual change in shoulder function (that cannot be
attributed to measurement error). For the domains, the
SEM varied from 8.3% to 10.1%, resulting in an SDCExcluded: re-test beyond 30 day interval
N= 3
Participated before re-testing was introduced
N= 21
    
Did not complete baseline measurements
N= 16
Did not complete re-test measurements
N= 15
the study.
Table 2 Demographic data and data from the OSIS, SST,
OSS, and DASH at baseline and retesting
Baseline assessment Reliability cohort
138 99
Mean age yrs (SD) 32 (12) 32 (14)
Gender (male vs female) 98 (71%) vs 40 (29%) 66 (67%) vs 33 (33%)
Dislocated shoulder
Right 72 (53%) 54 (55%)
Left 59 (43%) 40 (40%)
Both 6 (4%) 5 (5%)
Dominant side dislocated 72 (53%) 53 (54%)
Date first dislocation
<1 month 8 (6%) 8 (8%)
1 - 6 months 21 (15%) 17 (17%)
>6 months – 2 years 40 (29%) 25 (25%)
>2 years 67 (49%) 49 (50%)
OSIS (0 – 48)* 27.3 (9.1) 27.6 (9.7) ¶
SST (0 – 12)* 8.8 (3.1) 8.8 (3.2) ¶
OSS (48 – 0)* 23.7 (7.8) 22.8 (8.3) ¶
DASH (100 – 0)* 22.2 (16.7) 22.7 (18.3) ¶
*ranges reflect most impaired to least impaired function.
¶No significant change in shoulder function (OSIS, SST, OSS, DASH) was
observed at retest compared with baseline.














1 ,302 ,402 ,662 ,743 ,357 ,779
2 ,145 ,375 ,761 ,830 ,192 ,725
3 ,396 ,604 ,417 ,625 ,531 ,818
4 ,339 ,546 ,523 ,693 ,449 ,809
5 ,125 ,653 ,296 ,571 ,300 ,617
6 ,152 ,560 ,470 ,671 ,281 ,675
7 ,028 ,375 ,706 ,793 ,086 ,624
8 ,407 ,665 ,230 ,494 ,577 ,757
9 ,323 ,704 ,297 ,579 ,504 ,766
10 ,374 ,648 ,332 ,576 ,531 ,783
11 ,659 ,451 ,299 ,423 ,740 ,822
12 ,608 ,469 ,396 ,520 ,690 ,855
13 ,694 ,533 ,075 ,269 ,819 ,767
14 ,375 ,147 ,738 ,674 ,338 ,717
15 ,582 ,378 ,185 ,295 ,654 ,670
16 ,535 ,020 ,578 ,458 ,463 ,652
17 ,624 ,402 ,156 ,279 ,704 ,693
18 ,204 ,277 ,732 ,749 ,219 ,686
19 ,753 ,327 ,113 ,192 ,805 ,703
20 ,792 ,051 ,173 ,102 ,749 ,600
21 ,738 ,155 ,364 ,323 ,715 ,733
Scores
≧ 0.50 9 8 7 12 12 21
Factor loadings ≥0.50 are appropriate (bold). Best results are with the 1-factor
model in which all questions score at least 0.50.
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Tables 4 and 5.
Reliability
The WOSI test and retest scores are shown in Table 4.
The mean WOSI total score at baseline was 971 (46.0%).
The mean total WOSI retest score was 959 (45.7%). For
the four domains, scores expressed as a percentage
ranged from 60.2% to 82.6% at baseline and from 37.8%
to 60.6% at retest.
Regarding the WOSI total, the ICC (95% CI) was 0.92
(0.88–0.95), indicating excellent reliability. For the
WOSI domains, the ICC ranged from 0.88 (0.82–0.92)
to 0.90 (0.85–0.93).
Construct validity
Correlations are summarised in Table 1. The correlation
between the instability-specific WOSI and OSIS was
0.82 (≥0.70 expected). The correlations between the
WOSI and the shoulder-specific SST, OSS, and DASH
were −0.66, 0.79, and 0.81, respectively (≥0.60 expected).
The correlations between both the total WOSI score
and WOSI domains and the SF-36 domains are presented
in Table 6. The correlation between the WOSI and OSIS
was at least 0.10 higher than all other correlations, except
the correlation between the total WOSI score and SF-36
Bodily pain (0.76) and between the WOSI Physical
functioning domain and SF-36 Bodily pain (both 0.76).Correlations between similar WOSI and SF-36 domains
were highest, as expected, except for WOSI Emotional
function (0.27). Three of four correlations between similar
WOSI and SF-36 domains were at least 0.40.
In total, 76% of the results were in accordance with
the hypotheses.
Floor and ceiling effects
Floor and ceiling effects are presented in Table 5. No
floor or ceiling effects were found. When considering
the SDC, however, more than 15% of the scores in two
subdomains were within the SDC from the lowest possible
score (23% and 41%), and more than 15% of the scores in
three subdomains were within the SDC from the highest
possible score (20%, 25%, 26%).
Discussion
International adoption and validation of measurement
tools helps us to exchange results globally in a standardised
way, thereby enabling international evaluation to optimise
Table 4 Test–retest reliability (ICC) and the standard error of measurement (SEM) for the WOSI
N = 99 Mean (SD) SEM ICC (95% CI)
Baseline Re-test Change
WOSI
Total 971 (482) 959 (509) −12.1 (199.5) 174 0.92 (0.88-0.95)
Total as % 46.0 (22.3) 45.7(24,2) - 0.6 (9.5) 8.3 0.92 (0.88-0.95)
Domain as %
Physical 60.2 (24.0) 60.6 (24.7) 0.4 (11.2) 8.3 0.90 (0.85 – 0.93)
sp/rec/wrk 47.7 (27.8) 49.6 (28.5) 1.9 (12.7) 9.4 0.90 (0.85 – 0.93)
Lifestyle 56.5 (24.3) 55.8 (25.4) - 0.7 (12.3) 8.8 0.88 (0.83 - 0.92)
Emotion 36.8 (27.5) 37,8 (30.2) 1.0 (14.4) 10.1 0.88 (0.82 - 0,92)
Scores are presented for the total WOSI score (range 0–2100), the total WOSI score expressed as a percentage (range 1–100), and all WOSI subdomains.
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WOSI is the most thoroughly studied PROM to evaluate
shoulder functioning in patients with shoulder instability.
It has officially been validated in five other languages since
its development in English. Measurement properties of the
original WOSI and subsequent validation studies are
summarised in Table 7.
Translating the WOSI into Dutch did not incur difficul-
ties and resulted in a well-translated and comprehensive
Dutch version.
Regarding the structural validity, we were unable to
confirm the validity of the four domains of the WOSI.
An exploratory factor analysis suggested a one-factor
model, but this model fit even worse. The factor struc-
ture and the value of the four domains of the WOSI
therefore remain unclear. Apparently, there is no clear
distinction between the questions about symptoms,
physical functioning, and emotional aspects. Also, when
reading the questions, there is a lack of face validity of
the four dimensions. For example, questions about fear of
falling or sleeping are included in the lifestyle subscale,Table 5 Floor and ceiling effects and the smallest
detectable change in the WOSI









WOSI Floor Ceiling Floor Ceiling
total No No 23.0 0-23 77-100 17% 5%
Domain
physical No No 23.1 0-23.1 76.9-100 3% 26%
sp/rec/
wrk
No No 26.0 0-26 74.0-100 23% 20%
lifestyle No No 24.4 0-24.4 74.6-100 9% 25%
emotion No No 28.1 0-28.1 71.9-100 41% 10%
From left to right are presented; absolute floor and ceiling scores. The smallest
detectable change (SDC) with its ranges, and the percentage of scores that fell
within the SDC-range for both extremes. Scores are presented for the total
WOSI score and all WOSI subdomains.which may actually measure emotional aspects and
symptoms, respectively. Also one may wonder whether a
question about ‘feel the need to protect your arm during
activities’ refers to functioning or emotional aspects. The
subscales should therefore be used with caution.
A high Cronbach’s α of 0.96 for the total WOSI score
and 0.93–0.95 for the subscales were found, which
exceeded those in previous validation studies (ranging
from 0.84 to 0.93). Compared with other Dutch-validated
PROMs, Cronbach’s α of the WOSI was higher than that
of the SST (0.78), OSS (0.92), or DASH (0.95) [26,35,39].
However, Cronbach’s α of the WOSI total score was highly
affected by the large number of items.
This study is the second one to report on measurement
errors of the WOSI. Cacchio et al. [15] reported an SEM
of 71 and an SDC of 196 in 64 patients. We found much
higher SEM and SDC values (174 and 483, respectively),
indicating that a patient has to improve at least 23%
of the total score (483/2100 possible points) to ensure
an improvement beyond measurement error. It shouldTable 6 Observed correlations between the WOSI






PF −0.69 0.63 0.71 0.66 0.46
RF −0.60 0.56 0.60 0.54 0.40
RE −0.48 0.44 0.42 0.46 0.37
MH −0.28 0.23 0.23 0.30 0.27
V −0.39 0.35 0.31 0.45 0.31
SF −0.51 0.46 0.51 0.46 0.39
BP −0.76 0.76 0.71 0.67 0.46
GH −0.36 0.35 0.28 0.35 0.27
Expected correlations ≥ 0.4 between similar domains are expressed in bold.
PF = Physical Functioning, SF = Social Functioning, GH = General Health,
V = Vitality, MH =Mental Health, RE = Role Emotional, RF = Role Functional,
BP = Bodily Pain.







Floor/ ceiling MIC SRM & ES
Kirkley et al. [7] Total: 300 N = 33 N = 51 N = 47 (baseline) NA NA NA SRM 0.931
Not specified item reduction 0,494 (2wks) DASH 0.768







Salomonsson et al. [11] Total: 99 N = 22 N = 32 N = 22 NA Not found NA N = 22
22 surgery α = 0.89 0.94 (2 mnts) VAS function 0.80 SRM 1.40
32 partly surgery EQ-5D 0.44 ES 1.67
45 healthy N = 32 Rowe 0.59
Hatta et al. [13] Total: 85 N = 85 N = 59 N = 85 NA NA NA NA











Hofstaetter et al. [12] Total: 86 N = 24 N = 25 Rowe 0.627 NA High ceiling in
healthy shoulders
NA NA
24 surgery α = 0.92 0.92 (24–72 hr) UCLA 0.609










Drerup et al. [14] Total: 30 N = 29 N = 29 ASES 0,58 NA Not found NA NA
Not specified α = 0.89 0.87
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Table 7 Measurement properties of the WOSI as presented in the original article and subsequent validation studies
(Continued)
Cacchio et al. [15] Total: 64 N = 64 N = 64 DASH 0.79 SEM 71 Not found 40 N = 39
Not specified α = 0.93 0.95 (3 days) SF-36 0.11 SDC 196 0 SRM 1.94
N = 20 ES 1.47
0.92 (14 wks)
Measurement properties include the internal consistency (Cronbach’s α), intraclass correlation coefficient (ICC), construct validity (Pearson’s correlation coefficient),
standard error of measurement (SEM), smallest detectable change (SDC), floor- and ceiling effects, minimum important change (MIC), and sensitivity to change
[standardised response mean (SRM) and effect size (ES)]. NA means not assessed.
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one changed score in one individual patient. When
measuring change in a group of patients (as in a study),
the measurement error of the mean change score is much
lower (in fact, SDC/√n).
With an ICC of 0.92 for the total WOSI score and 0.88–
0.90 for the subscales, the reliability of the Dutch version
is considered very good. Including 99 patients in our test–
retest analysis, our population was larger than populations
described in previous validation studies (25–64 patients).
Our study is most similar to those performed by
Kirkley et al. and Hatta et al. [7,13] regarding both
the length of the test–retest interval (both 2 weeks)
and the size of the patient population (51 and 59 patients,
respectively). These studies reported ICCs of 0.94 and
0.91, respectively, for the WOSI total score.
Studies performed by Salomonsson et al., Hofstaetter
et al., and Cacciho et al. [11,12,15] all had smaller
patient populations (32, 25, and 30, respectively) and
differed in their treatment-free test–retest interval.
Hoffsaetter et al. and Cacchio et al. used a test–retest
interval of 24–72 h and 3 days or 14 weeks, respectively.
Salomonsson et al. used an interval of 2 and 3 months,
respectively. These studies nevertheless present comparable
ICCs for the total WOSI score, varying from 0.91 to
0.95. Only Drerup et al. [14] reported a lower ICC
(0.87), without defining either its test–retest interval
or patient population.
To assess the construct validity, Kirkley et al. calcu-
lated correlations with the DASH, the UCLA shoulder
rating scale, the Constant score, the Rowe rating scale,
ASES, and SF-12. The original Rowe and Constant
scores are not PROMs but observer-based measurement
instruments, and the Constant score is considered not
applicable to shoulder instability [50,51]. We used only
PROMs for the Dutch validation. Because the SST and
OSS are validated in Dutch, and because preliminary re-
sults of the Dutch OSIS validation are good, we decided
to use these instruments instead of the UCLA shoulder
rating scale and ASES. It should be noted, however, that
the WOSI is validated against the OSIS, and the OSIS is
validated against the WOSI. Unfortunately, there is no
gold standard or other validated PROM for shoulder in-
stability that could be used to assess construct validity.Therefore, we chose this method but also included other
instruments. The high correlation between WOSI and
OSIS (0.82) means that the two questionnaires are meas-
uring the same construct, but it does not guarantee that
both instruments are valid.
With 76% of our predetermined hypothesis being con-
firmed, construct validity was considered good.
Despite the fact that few questions of the DASH as-
sessment and WOSI overlap, a high correlation was ob-
served (0.81). Both the original article [7] and studies
using WOSI translations in Japanese and Italian also
found a higher correlation with the DASH and Quick
DASH than with other outcome measures (0.77, 0.63,
and 0.79, respectively).
Regarding the total WOSI score, no floor or ceiling ef-
fects were found, as also described by McHorney [49].
When the SDC (23.0%) is taken into account, however, a
total of 23 scores (17%) were within the SDC from the
lowest possible score. No real deterioration beyond
measurement error could be detected in these patients.
A strong aspect of this study is our large population of
patients with shoulder instability and without missing
values regarding the PROM questions. Although needed
to perform this study, a weak aspect might be the total
number of questions posed to our patients. Completing
six questionnaires at once requires considerable time
and concentration, during which patients might lose
their focus. Another weak point is the fact that we used
a preliminary version of the Dutch OSIS to validate the
WOSI. Official translation and validation is a subject of
future, yet unpublished studies in our institution.
Future studies should focus on determining the respon-
siveness and the minimum important changes (MIC)
needed in the WOSI. This information can be used to de-
termine whether observed changes are important to patients
and to determine the number of patients who achieve a
change greater than the MIC (e.g., responders in an inter-
vention study). The numbers of responders can then be
compared between groups in clinical trials [52].
Conclusion
The Dutch version of the WOSI showed good reliability
and construct validity in a cohort of patients with shoulder
instability, but the factor structure remains unclear.
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